Financhill
Back

Ligand Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

LGND
Ligand Pharmaceuticals, Inc.

Last Price:
$183.59
Seasonality Move:
3.12%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing slight selling pressure.

Ligand Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 185.49 Sell
20-day SMA: 191.01 Sell
50-day SMA: 193.4 Sell
200-day SMA: 162.46 Buy
8-day EMA: 186.64 Sell
20-day EMA: 189.72 Sell
50-day EMA: 191.74 Sell
200-day EMA: 168.59 Buy

Ligand Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.88 Sell
Relative Strength Index (14 RSI): 41.2 Sell
Chaikin Money Flow: -44354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (186.31 - 198.41) Sell
Bollinger Bands (100): (183.92 - 200.74) Sell

Ligand Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ligand Pharmaceuticals, Inc. Stock

Is Ligand Pharmaceuticals, Inc. Stock a Buy?

LGND Technical Analysis vs Fundamental Analysis

Sell
47
Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Is Ligand Pharmaceuticals, Inc. a Buy or a Sell?

Ligand Pharmaceuticals, Inc. Stock Info

Market Cap:
3.6B
Price in USD:
183.98
Share Volume:
163.8K

Ligand Pharmaceuticals, Inc. 52-Week Range

52-Week High:
212.49
52-Week Low:
93.58
Sell
47
Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Ligand Pharmaceuticals, Inc. Share Price Forecast

Is Ligand Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Ligand Pharmaceuticals, Inc.

Is Ligand Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $1.18 per share.

Technical Analysis of Ligand Pharmaceuticals, Inc.

Should I short Ligand Pharmaceuticals, Inc. stock?

* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.